Integrated approach to HPLC method development: Using all the tools in the chromatographer s toolbox

Similar documents
Routine MS Detection for USP Chromatographic Methods

UPLC Method Development and Validation

Simultaneous Determination of Paraquat and Diquat in Environmental Water Samples by HPLC-MS/MS

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

Reversed Phase Solvents

Developing Analytical Chromatographic Methods for Pharmaceutical Stability Investigations

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

Live Webinar : How to be more Successful with your ACQUITY QDa Detector?

Chromatographic Analysis

LC and LC/MS Column Selection Flow Chart

OVERVIEW INTRODUCTION. Michael O Leary, Jennifer Gough, Tanya Tollifson Waters Corporation, Milford, MA USA

ACD/AutoChrom Assisted Method Development for Challenging Separations. Vera Leshchinskaya February 7, 2018

UPLC for Synthetic Peptides: A User`s Perspective

A Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone

Webinar: How to be More Successful with your ACQUITY QDa Detector Eric van Beelen

Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

Analysis - HPLC A.136. Primesep 5 µm columns B.136

Hypericin Analysis by LC/MS

LC Technical Information

637. Thiamethoxam. HPLC method

Comparison of different aqueous mobile phase HPLC techniques

penta-hilic UHPLC COLUMNS

The Secrets of Rapid HPLC Method Development. Choosing Columns for Rapid Method Development and Short Analysis Times

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

Chem 230, Fall, 2014 Homework Set # 3 Short Answer SOLUTIONS

Welcome to our E-Seminar: Choosing HPLC Columns for Faster Analysis Smaller and Faster

Luna 2.5 µm C18(2)-HST. Advantages of 2.5 µm for increasing the speed of analysis while maintaining high efficiency

DEVELOPMENT AND VALIDATION OF NEW ANALYTICAL METHOD FOR BIOACTIVE COMPOUNDS

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

Transferring Yesterdays Methods to Tomorrows Technology: The Evolution from HPLC to UPLC TM

Developing a fast, generic method for rapid resolution LC with quadrupole MS detection. Application Note

Shodex TM ODP2 HP series columns

Introduction to Capillary GC. Page 1. Agilent Restricted February 2, 2011

InertSustainSwift C8

Packings for HPLC. Packings for HPLC

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Analysis of Organic Light Emitting Diode Materials by UltraPerformance Convergence Chromatography Coupled with Mass Spectrometry (UPC 2 /MS)

Streamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System

Acclaim Mixed-Mode WCX-1

Technical Note. Introduction

M > ACN > > THF

DEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR

penta-hilic UHPLC COLUMNS

Dilution(*) Chromatography

Chaotropic Effect in Reversed-phase HPLC: A Review

Analysis of Synthetic Cannabinoids and Metabolites: Adding New Compounds to an Existing LC-MS/MS Method

The Theory of HPLC. Ion Pair Chromatography

Confirmation of In Vitro Nefazodone Metabolites using the Superior Fragmentation of the QTRAP 5500 LC/MS/MS System

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

Chromatography and other Separation Methods

Chemistry Instrumental Analysis Lecture 28. Chem 4631

Introduction to Capillary GC

How proteins separate on reverse-phase HPLC

Chromatographic Methods: Basics, Advanced HPLC Methods

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

Unexpected Peaks in Chromatograms - Are They Related Compounds, System Peaks or Contaminations? From the Diary of an HPLC Detective

(HILIC) Bill Champion Agilent Technologies, Inc opt 3/opt3/opt 2 HILIC - Agilent Restricted

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

Agilent s New Weak Anion Exchange (WAX) Solid Phase Extraction Cartridges: SampliQ WAX

Basic Principles for Purification Using Supercritical Fluid Chromatography

LC-MS compatible Separation of the Fungicide Spiroxamine

Chemistry Instrumental Analysis Lecture 37. Chem 4631

ACE SuperC18. ACE UHPLC and HPLC Columns. Ultra-Inert UHPLC and HPLC Columns with Extended ph Stability

HICHROM. Chromatography Columns and Supplies. LC COLUMNS SIELC Primesep. Catalogue 9. Hichrom Limited

Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

for Acclaim Mixed-Mode HILIC-1 Column

Selecting an LC/MS Interface Becky Wittrig, Ph.D.

8. Methods in Developing Mobile Phase Condition for C18 Column

DEVELOPMENT OF HPLC METHOD FOR ANALYSIS OF NITRITE AND NITRATE IN VEGETABLE

Application Note LCMS-112 A Fully Automated Two-Step Procedure for Quality Control of Synthetic Peptides

Construction and Use of API Single- Quadrupole MS Spectral Libraries.

Determination of Pharmaceuticals in Environmental Samples

2007 Waters Corporation. Application of UPLC to Peptide Mapping

Mass Spectrometry. Hyphenated Techniques GC-MS LC-MS and MS-MS

CHAPTER CHROMATOGRAPHIC METHODS OF SEPARATIONS

Acclaim Mixed-Mode WAX-1 Columns

for Acclaim Mixed-Mode WCX-1

THE INFLUENCE OF PERCHLORATE ION CONCENTRATION ON THE RETENTION OF FLUOROQUINOLONES IN RP-TLC

2.1 2,3 Dichloro Benzoyl Cyanide (2,3 DCBC) and survey of. manufactured commonly for the bulk drug industry, few references were

Chapter 5. Irbesartan. Page no. 64 to 80

Automatization for development of HPLC methods

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

Strategies for the Analysis of Therapeutic Peptides in Biofluids by LC-MS/MS. Lee Goodwin

[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Ion Chromatography. Anion Exchange. Chromatography Ion Exchange Theory. Dr. Shulamit Levin

Gemini-NX Performance paired with Axia Technology

Method Development Kits

Too Polar for Reversed Phase What Do You Do?

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

High Performance Liquid Chromatography

High Performance Liquid Chromatography

High Pressure/Performance Liquid Chromatography (HPLC)

Prep 150 LC System: Considerations for Analytical to Preparative Scaling

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Mechanisms of retention in HPLC

Successfully Scaling and Transferring HPLC and UPLC Methods

Transcription:

Integrated approach to HPLC method development: Using all the tools in the chromatographer s toolbox Rosario LoBrutto Pharmaceutical and Analytical Development Novartis Pharmaceuticals

Overall Strategy Determine aim of analysis Look at structure (estimate pk a ) or use ACD (Advanced Chemistry Development) Try to use shorter columns for scouting experiments (5cm x 4.6 mm )- 3 um or use Acquity system with 10 cm x 2.1 mm, 1.7 um particles Use 35-45C as starting temperature. Run probe linear gradient with hold at high organic on short column, 5cm column Run ph studies isocratically to determine optimal ph (5 cm column) Acquity system very effective for doing so Run linear gradient with hold at high organic with optimized ph on 5 cm x 4.6 mm column If sufficient resolution Finished If need more resolution then go to 15 cm x 3 mm id column If resolution obtained- Finished If desired resolution not obtained use AMDS system (need to optimize gradient and selectivity) Use AMDS system for gradient optimization on 15 cm x 3 mm id column. (2 organics, steep/shallow gradient)- we will discuss today. Sample Prep Use methanol as sample prep solvent if using second dilution. (check for sample reactivity) If using methanol for only dilution look at impact on peak shape (diluent/mobile phase mismatch for components with k <2) Sample prep constitutes apx. 70% of solvent usage, try to use methanol if possible.

First Step: pk a Estimation Using ACD Software Product T is a diprotic base with two pk a s 3.3 and 5.3 estimated by ACD It has two pk a values and at mobile phase ph values between 3 and 5, multiple species exist. Two equilibria could be written for this amphoteric species Since pk a s are close to one another (<4 pk a units apart) the inflection points overlap making titration and or chromatographic pk a prediction difficult. At ph=4.3 basic site (A) will be predominately neutral (90%) and the other basic site (B) will be predominately ionized (90%).

Estimating Isocratic Conditions Dwell volume correction ~1-2 min t R = 6.0 Column: Luna C8(2) 150x4.6 mm Inj. Vol.: 10 µl Flow: 1.0 ml/min Wavelength: 300 nm Col. Temp.: 35 C Time Flow %A %B 1 1 95 5 2 10 1 5 95 %A 0.2% H 3 PO 4 (v/v) ph 1.90 %B - Acetonitrile 10 90 minutes AC 9% ACN min 9% = 6 min. ACN min. 2 - min. dwell ( ) vol. 36%ACN = +/- 10% ACN Initially a steep gradient was run to estimate the isocratic elution conditions in order to study the effect of ph on analyte retention.

Retention Dependence on Mobile Phase ph Chromatographic conditions: Column: Phenomenex Luna 3u C8(2) [150x4.6mm, 3µm] MP: 10 mm K 2 HPO 4 :ACN (71:29,v/v) ph adj. w/ H 3 PO 4 Flow rate: 1.0 ml/min Injection Vol.: 10 µl Wavelength: 247 nm Column Temp.: 35 C ph tr 6.1 49.8 4.6 49.1 3.6 34.3 2.6 11.2 2.1 6.0 1.6 3.8 ph 6.1 ph 4.6 ph 3.6 ph 2.6 ph 2.1 ph 1.6 Initial isocratic conditions predicted from probe gradient run correlates very well with actual retention obtained at isocratic conditions. ph 6 is the optimal ph to run for the analysis. Check which wavelength gives the best sensitivity Time (min.) Try 5 cm x 4.6 mm column on conv. HPLC system Try 10 cm x 2.1 mm column on Acquity system

What should the starting ph be in order to analyze this molecule in its neutral form? The downward pk a shift for basic analytes must be accounted for. The working ph should be at least 2 ph units above the basic analyte pk a to be fully neutral. The upward ph shift of the aqueous acidic buffer upon addition of the organic must be accounted for. Example: The higher pk a of Product T is 5.3 and initial eluent conditions are: 30% MeCN and 70% Buffer. What should the ph of the buffer be in order to obtain the basic analyte in its neutral form? 5.3 (3*0.2) = 4.7 4.7 + 2 = 6.7 3 * 0.2 = 0.6 6.7 0.6 = 6.1 Downward analyte pk a shift. ph at which basic analyte would be neutral Upward ph shift of aqueous acidic buffer upon addition of organic Max ph of buffer in order to have analyte in fully neutral form. This prediction agrees well with the experimental!!

(Option 1)Chaotropic Effect: Increasing retention in low ph region 0.2% H 3 PO 4 ph 1.90 1 0.3% H 3 PO 4 ph 1.86 2 Chromatographic Conditions Column: Luna C8(2) 150x4.6 mm MP: Aqueous :ACN (71:29, v/v) Wavelength: 247 nm Col. Temp.: 35 C Inj. vol.: 10 µl 0.1% TFA ph 1.96 3 0.1% HClO 4 ph 1.70 4 Chaotropic anions, TFA and HClO 4 interact with positively charged analyte and lead to an increase in the analyte retention. Retention decreases from ph 1.90 to 1.86 for MP with H 3 PO 4. Indicates analyte not completely ionized in this ph region. TFA is MS compatible however is not the best MS mobile phase additive to employ (ion suppression in gas phase) so went to high ph analysis.

Increase of analyte efficiency and reduction of peak tailing Chromatographic overlays of Labetalolanalyzed at different analyte concentrations using increasing mobile phase concentration of perchlorate anion Chromatographic conditions: Analyte load: 3.3, 6.5, 31.2 mg, (a) 75%: 0.1 v/v% H3PO4: 25% acetonitrile, (b) 75%: 0.05 v/v% HClO4: 25% acetonitrile, (c) 75%: 0.2 v/v% HClO4: 25% acetonitrile, (d) 75%: 0.4 v/v% HClO4: 25% acetonitrile, (e) 75%: 0.5 v/v% HClO4: 25% acetonitrile

Increase of analyte efficiency and reduction of peak tailing Fig. 5. Chromatographic overlays of Dorzolamide HClanalyzed at different analyte concentrations using increasing mobile phase concentration of perchlorate anion Chromatographic conditions: Analyte load: 1.4, 5.2, 9.2, 48 mg, (a) 90%: 0.1 v/v% H3PO4: 10% acetonitrile, (b) 90%: 0.05 v/v% HClO4: 10% acetonitrile, (c) 90%: 0.2 v/v% HClO4: 10% acetonitrile, (d) 90%: 0.4 v/v% HClO4: 10% acetonitrile, (e) 90%: 0.5 v/v% HClO4: 10% acetonitrile

Effect of analyte load and perchlorate counteranion conc. on labetalol apparent efficiency and tailing factor. Chromatographic conditions: Analyte load: 0.06-31.2 mg, 75% water: 25% acetonitrile. Water adjusted with 0.025-0.5 v/v% HClO4. (A) N (h/2) vs. perchlorate concentration. (B) Tailing factor vs. perchlorate concentration.

Effect of tetrafluoroborate concentration on analyte apparent efficiency and tailing factor. Mobile phase: 0.1 v/v% phosphoric acid + xbf4 [1 mm 50 mm]: acetonitrile, Ophthalmic compounds (10% acetonitrile), phenols (25% acetonitrile), (A) N(h/2) vs. tetrafluoroborate concentration. (B) Tailing factor vs. tetrafluoroborate concentration.

Van Deemter plots of plate height (H) versus flow rate. Mobile phases (A) Dorzolamide HCl: 90% water: 10% acetonitrile. Water adjusted with either 0.1 v/v% phosphoric acid or 0.5 v/v% HClO4, Phenol: 75% water: 25% acetonitrile. Water adjusted with either 0.1 v/v% phosphoric acid or 0.5 v/v% HClO4. (B) Benzylamine: 95% water: 5% acetonitrile. Water adjusted with either 0.1 v/v% phosphoric acid or 0.5 v/v% HClO4, Toluene: 50% water: 50% acetonitrile. Water adjusted with either 0.1 v/v% phosphoric acid or 0.5 v/v% HClO4.

Option 2- Analysis of Analyte (Free Base) as Neutral Species AU 0.24 0.22 0.20 0.18 0.16 0.14 0.12 0.10 0.08 %A = 10 mm Ammonium Acetate ph 5.8 and 6.9 %B = Acetonitrile Diluent = 0.05% H 3 PO 4 :ACN (50:50) 4 days old solution TAE226 1 Chromatographic Conditions: Column: Luna C8(2) 150x4.6 mm MP: Aqueous :Acetonitrile Wavelength: 247 nm Col. Temp.: 35 C Flow: 1 ml/min Inj. Vol.: 10 µl 0.06 AU 0.04 0.02 0.00 0.24 0.22 0.20 0.18 0.16 0.14 0.12 0.10 0.08 0.06 0.04 0.02 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 Minutes %A = 10 mm Ammonium Carbonate ph 6.7 %B = Acetonitrile Diluent = 0.05% H 3 PO 4 :ACN (50:50) 1 day old solution TAE226 2 Time Flow %A %B 1 1 95 5 2 20 1 5 95 3 23 1 5 95 %A: Aqueous %B: ACN 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 Minutes Analyte is in neutral form at the mobile phase ph of the aqueous phases used. Ammonium Carbonate and ammonium acetate have a UV cutoff < 220 nm. Both buffers are compatible with LC-MS. Ammonium carbonate buffer may be undesired because it can form CO 2 and alter the mobile phase ph.

Spectral Purity: Diode array % Area = 94.9% apex 210.8 213.2 265.0 280.4 281.6 +5% -5% +5% 331.5-5% and apex 250.00 300.00 350.00 nm Diode array spectra show that this main peak is not spectrally homogenous. Need to perform method optimization experiments to resolve the impurity from active. LC-MS studies were also done in parallel. Chromatographic Conditions: Column: Luna C8(2) 150x4.6 mm MP: 10 mm NH 4 OAc:Acetonitrile Col. Temp.: 35 C Flow: 1.0 ml/min Inj. Vol.: 10 µl Time Flow %A %B 1 1.0 95 5 2 20 1.0 5 95 3 23 1.0 5 95 %A: 10 mm NH 4 OAc, ph 5.8 %B: ACN

Spectral Purity: MS Product T free base Chromatographic Conditions: Column: Luna C8(2) 150x4.6 mm MP: Aqueous :Acetonitrile Wavelength: 247 nm Col. Temp.: 35 C Flow: 1 ml/min, split 10:1 Inj. Vol.: 10 µl Time Flow %A %B 1 1 95 5 2 20 1 5 95 3 23 1 5 95 %A: 10 mm Amm. Acetate, ph 5.8 %B: ACN ESI: + ion mode Single Quadrupole, Open access Capillary: + 3.5 kv Cone: 25 V Source Temp: 150C Cone Temp: 20C Desolvation Temp: 400C Cone gas flow: 113 L/hr Desolvation gas flow: 419 L/hr

Using open access MS and diode array spectra in parallel -5%, rise of peak Apex Indicates peak is not spectrally homogenous. [M+H] ion of active = 469 [M+H] ion of impurity = 438 Indicates impurity has odd number of nitrogens. 210.8 213.2 265.0 280.4 281.6 +5% 331.5 +5%, fall of peak -5% and apex 250.00 300.00 350.00 nm We will revisit the mass spectra once we separate!!!

Waters Automated Method Development System (AMDS) The Waters AMDS was used for method optimization by varying several chromatographic parameters in order to satisfy a users set criteria. AMDS varies the following chromatographic parameters: Organic solvent Gradient Column temperature Column Analytical goals for the Analysis of Product T on the AMDS: Organic solvents: Methanol, Acetonitrile Aqueous: 10 mm NH 4 OAc, ph 5.8 Columns: Luna C18 (2) 3µm(150x4.6 mm), Sunfire C18 3.5µm (150x4.6 mm) Resolution more important than run time Runtime < 10 min. Minimum Resolution > 3.0 (between identified peaks) Pressure < 3000 psi

AMDS for Method Optimization 1 Luna C18(2), 3um, 150x4.6 mm 35 C Sunfire C18, 3.5 µm, 150x4.6 mm 35 C 2 35 C 35 C 3 50 C 50 C 4 50 C 50 C Time (min.) Time (min.) 1 (Steep gradient) 5% - 90% Methanol in 6 min 2 (Shallow gradient) 5% - 90% Methanol in 17 min 3 (Steep gradient) 5% - 90% Methanol in 6 min 4 (Shallow gradient) 5% - 90% Methanol in 17 min Flow rate = 0.8 ml/min Future suggestion: Gradients used should be 15 95% Methanol

AMDS for Method Optimization Luna C18(2), 3µm, 150x4.6 mm Sunfire C18, 3.5 µm, 150x4.6 mm 1 35 C R s =2.0 35 C R s =2.3 2 35 C R s =2.9 35 C R s =3.0 50 C R s =2.1 50 C R s =2.1 3 4 50 C R s =2.6 50 C R s =2.2 Time (min.) 1 (Steep gradient) 5% - 85% Acetonitrile in 6 min 2 (Shallow gradient) 5% - 85% Acetonitrile in 17 min 3 (Steep gradient) 5% - 85% Acetonitrile in 6 min 4 (Shallow gradient) 5% - 85% Acetonitrile in 17 min Time (min.) Flow rate=1.5 ml/min

AMDS for Method Optimization Luna C18(2), 3 µm, 150x4.6 mm 10 mm NH 4 OAc, ph 5.8:ACN Shallow gradient (5%-85% ACN in 17 min. 35 C Sunfire C18, 3.5 µm, 150x4.6 mm 10 mm NH 4 OAc, ph 5.8, :ACN Shallow gradient (5%-85% ACN in 17 min.) 35 C TAE226 TAE226 Baseline Rs obtained 0 19 Time (min.) Acetonitrile is the preferred organic solvent for this separation. Greater resolution between the critical pair is observed on the Sunfire column. Further optimization is necessary to shorten run time.

Entered chromatographic results into DryLab to predict minimum resolution between active and impurity. Used the resolution map to determine optimal gradient run time and temperature condition for analysis. Predicting Method Conditions Using DryLab DryLab Predicted Chromatogram [10] TAE226 R s = 2.5 Gradient Conditions Time %B 0 35 10 75 12 75 [1] [2] [3] [5] [4] [6] [7] [8] [9] 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 [11] Impurity Time (min.) [12] [13] [14] [15] [16] [17] Col. Temp. = 35 C Flow Rate = 1.5 ml/min Sunfire C18, 3.5 µm, 150x4.6 mm 10 mm NH 4 OAc, ph 5.8, :ACN Resolution Map

DryLab Predicted Chromatogram DryLab Prediction vs. Actual Chromatogram [10] TAE226 R s = 2.5 [1] [2] Actual chromatogram [3] [5] [4] [6] [7] TAE226 [8] [9] 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 [11] Impurity Time (min.) [12] [13] [14] [15] [16] R s = 3.1 R s = 2.98 [17] Chromatographic Conditions: Column: Sunfire C18, 3.5um, 150x4.6 mm MP: Aqueous:Acetonitrile Wavelength: 247 nm Col. Temp.: 35 C Flow: 1.5 ml/min Inj. Vol.: 10 µl Time Flow %A %B 1 1.5 65 35 2 10 1.5 25 75 3 12 1.5 25 75 Time (min.) %A: 10 mm NH 4 OAc, ph 5.8 %B: ACN DryLab predicted chromatogram and actual chromatogram are similar. Note that Drylab gives accurate predictions only if the analyte ionization state is not changing with increasing organic The run time was decreased without compromising the resolution between the active and the impurity.

Predict/Confirm possible deg. products of your analyte Forced Deg studies 50 C / 1 week, ph 1 A CA Product T Time Flow %A %B 1 1.5 65 35 2 10 1.5 25 75 3 15 1.5 25 75 %A = 10 mm NH 4 OAc, ph 5.8 %B = ACN Rs=3.0 B Time Flow %A %B 1 1.5 75 25 2 10 1.5 25 75 3 15 1.5 25 75 %A = 10 mm NH 4 OAc, ph 5.8 %B = ACN Rs=3.0 Time (min.) Sample was stressed at 50 C for 1 week in ph 1 diluent. Decreased the initial organic composition of the gradient from 35% to 25%. Carboxylic acid impurity has enhanced retention at lower organic. Resolution between active and impurity eluting after main component was not compromised.

FB- 25CV + TAE226 FB-1 100 2.31 2.51 % 4.64 MS analysis of Product T 9.28 RRT=1.00 7.64 7.81 RRT=1.04 9.58 2: Diode Array TIC 3.67e6 Time Flow %A %B 1 1.5 75 25 2 10 1.5 25 75 3 15 1.5 25 75 %A = 10 mm NH 4 OAc, ph 5.8 %B = ACN Sunfire C18, 4.6 x 150 mm, Flow 1.5 ml/min, split 10:1 Temp: 35C Cone voltage: 25 V, Single quad. 12.24 11.18 11.64 12.58-155 TAE226 FB-1 100 6.73 8.20 1: Scan ES+ TIC 2.32e7 8.50 10.09 % 7.57 10.58 3.57 5.71 5.51 6.54 9.68 11.19 11.51 11.75 0 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 Time

MS analysis confirmed the separation of the active from the MW 437 impurity FB- 25CV +1 TAE226 FB-1 807 (8.225) 100 469.18 FB- 25CV +1 1: Scan ES+ TAE226 FB-1 837 (8.531) 4.86e7 100 438.16 1: Scan ES+ 5.85e6 RRT=1.00, active [M+H] + RRT:1.04, Imp. [M+H] + % % 471.08 440.06 0 [2M+H] 100.19 155.62 214.09 242.19 255.11 315.23 721.16 348.40 434.62 506.91 577.06 652.27 696.09 813.47 831.58 891.09 941.49 976.06 m/z 100 200 300 400 500 600 700 800 900 1000 937.44 426.13 879.32 468.93490.83 698.75 729.26 768.65 811.19 940.86 73.24 213.97 256.62 327.39 394.23 580.22 665.19 907.94 974.79 0 m/z 100 200 300 400 500 600 700 800 900 1000 875.14 876.91 Product T Monoisotopic mass: 468.2 %A = 10 mm NH 4 OAc, ph 5.8 %B = ACN Sunfire, 4.6 x 150 mm, Flow 1.5 ml/min, split 10:1 Cone voltage: 25 V, Single quad. Impurity at RRT 1.04 Monoisotopic mass: 437.2

Evaluate the fragmentor voltage!! FB- 25CV +1 TAE226 FB-1 807 (8.225) 100 25V Single Quad 469.18 3:1 DS FB 60CV+1 1: Scan ES+ TAE 226 FB-2 805 (8.205) 4.86e7 100 60V Single Quad 438.16 469.18 3:1 3:1 DS 1: Scan ES+ 5.13e7 403.22 % % 471.08 471.08 372.20 0 100.19 155.62 214.09 242.19 255.11 315.23 721.16 348.40 434.62 506.91 577.06 652.27 696.09 813.47 831.58 891.09 941.49 976.06 m/z 100 200 300 400 500 600 700 800 900 1000 937.44 193.08 315.61359.54 491.09534.26 757.50 870.45913.51 937.57959.60 99.94 117.53 0 635.18 720.40 m/z 100 200 300 400 500 600 700 800 900 1000 DS loses methyl amine (31 dalton) to form stable ion (m/z 438). Note if too high a fragmentor voltage used fragment could not be deconvoluted from RRT:1.04 impurity [M+H]= 438. The proposed fragmentation pattern was confirmed by MS/MS analysis and deuterated experiments.

Conclusion Use ACD to estimate pk a of molecule and predict optimal ph for analysis Run steep gradient to predict isocratic conditions for further ph optimization Determine retention behavior of active as function of ph (isocratic)- use Acquity if possible Determine best mobile phase ph for further experiments Co-elution of impurities -Determine spectral purity with PDA spectra -LC-MS to elucidate spectral homogeneity (watch out for isomers) - Run all intermediates, precursors, forced deg. samples Method optimization -Use AMDS/Dry Lab for method optimization - Use MS to confirm the separation of active from possible co-eluting species MS/MS analysis can be performed for structural elucidation of impurities Deuterated experiments can be performed to support structural assignments

Acknowledgements A.Jones Frances Liu Y. Kazakevich Rich Vivilecchia James Mullins

Background Slides

Deuterated experiments Deuterium-exchange experiments can also be used to further elucidate and define structural detail. The fine structural details of analytes could be further defined by a deuterium-exchange experiment that measures the number of exchangeable protons in each molecule. The number of exchangeable protons in a molecule can be determined based on the mass shift. This technique allows an understanding of which protons are susceptible to exchange, but also can be used to differentiate compounds of the same molecular weight that have a different number of exchangeable protons.

H/D Exchange ESI (+) Product T: MW: 468 TAE226HJM 1 (0.010) 100 80:20, 0.1% HAc in water:mecn 80:20, 0.1% DAc in D 2 O:MeCN [M H +H] + m/z: 469.26 469.26 134144000 Scan ES+ 1.34e8 TAE226DJM 1 (0.010) 100 [M D +D] + m/z: 473.29 473.29 133832704 Scan ES+ 1.34e8 237.58 83394560 % 235.06 68251648 471.28 69046272 % 475.31 60137472 70.66 5281536 219.57 5555712 236.07 22932480 472.28 17641472 0 m/z 25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 96.74 15878144 221.21 5220352 238.59 30193664 476.32 16097280 0 m/z 25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 Deuterated exchange provides strong evidence to support degradation product and synthetic by-product elucidation.

H/D Exchange ESI (+) Product T COOH Impurity MW: 455 80:20, 0.1% HAc in water:mecn 80:20, 0.1% DAc in D 2 O:MeCN TAE226COOHIMPHJM 1 (0.010) 100 456.29 97509376 Scan ES+ 9.75e7 TAE226COOHIMPDJM 1 (0.010) 100 231.16 132763648 460.32 134135808 Scan ES+ 1.34e8 % 228.64 73752576 [M+H] + m/z: 456.29 % [M+D] + m/z: 460.32 458.30 33910784 232.17 49762304 462.33 52736000 229.65 25928704 70.66 10363904 59.57 8702976 214.03 7215616 459.31 8712192 455.28 4007936 63.48 8686592 463.34 12387328 0 25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 m/z 0 m/z 25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 Deuterated exchange provides strong evidence to support degradation product and synthetic by-product elucidation.

Case Study 1 Structural elucidation of compounds with the same mass AMINOINDANHJM 1 (0.010) 100 133.93 17542144 H 2 N Scan ES+ 1.75e7 AMINOINDAZOLEHJM 1 (0.010) 100 133.93 18857984 Scan ES+ 1.89e7 N N H NH 2 Monoisotopic Mass = 133.063997 Da Monoisotopic Mass = 133.089149 Da % 5-Aminoindazole [M+H] + m/z: 133.93 % 1-Aminoindan [M+H] + m/z: 133.93 134.81 2019264 134.81 1648576 0 m/z 40 60 80 100 120 140 160 180 200 220 240 260 0 63.36 803264 236.14 833792 m/z 40 60 80 100 120 140 160 180 200 220 240 260 Mass spectra of these different analytes are similar and the same [M+H] + ion obtained. Application of the nitrogen rule does not help (odd number of nitrogens in both). Deuterium exchange might help in structural elucidation since 5-aminoindazole has 3 exchangeable protons and 1-Aminoindan has only two exchangeable protons. 80:20, 0.1% HAc in water:mecn

HPLC analysis using on-line H/D exchange -00124 sepdeut 64 (1.173) 70.42 100 44221216 H 2 N 1: Scan ES+ 4.42e7-00124 sepdeut 121 (2.218) 70.42 100 50858368 1: Scan ES+ 5.09e7 N N H Monoisotopic Mass = 133.063997 Da 110.37 23715296 NH2 % % Monoisotopic Mass = 133.089149 Da 82.39 14369048 89.95 4668524 109.74 9259440 118.81 5108372 137.84 13203920 119.94 90.83 117.67 62.73 54.91 1470790 75.33 2919656 106.96 1275775 1714597 128.64 145.90 1078913 85.54 148.80 336865 603312 641714 915860 0 479128 82046 159.89 165.82 83869 93975 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145 150 155 160 165 m/z sepdeut 100 % -2 Increases by 5 1.23 2.28 Time (min.) 90.58 4815556 95.62 2176994 108.73 18946480 58.07 62.35 75.46 514849 85.16 104.69 805288 637793 0 445601 141258 159.26 165.69 263950 66237 70766 50 60 70 80 90 100 110 120 130 140 150 160 170 180 m/z 2: Diode Array TIC 9.01e6 114.78 8846600 117.04 1603168 134.18 1932328 136.96 11762256 144.90 2241068 148.93 Increases by 4 Conditions: 70% D2O: 30% MeCN, Flow: 0.5 ml/min. Symmetry Shield 50 x 4.6 mm, 5 um The mass of the first component on the chromatogram increases by 5 therefore 3 exchangeable protons are present, which suggests that this analyte is 5-aminoindazole. The mass of the second compound increases by 4 therefore only 2 exchangeable protons are present. Knowledge of the number of labile H atoms in a molecule is useful for comparing proposed impurity structures with that of the parent drug to determine the presence or absence of these functional groups.

HPLC References LoBrutto,R.*, Kazakevich, Y.V.* Chaotropic effects in RP-HPLC (Invited Review) for volume 44 of The Advances in Chromatography series, editors, Professor Eli Grushka and Nelu Grinberg (September 2005). LoBrutto, R. Normal Phase Stationary Phases (Encyclopedia chapter), Cazes, J., Editor, "Encyclopedia of Chromatography", New York, Marcel Dekker, 553-556 (2001). Grinberg, N., LoBrutto, R. Efficiency in Chromatography, (Encyclopedia chapter), Cazes, J., Editor, "Encyclopedia of Chromatography", New York, Marcel Dekker, 274-276 (2001). LoBrutto, R., Kazakevich, Y.V. Retention of Ionizable Components in Reversed Phase HPLC (Book Chapter), Practical Problem Solving in HPLC, Wiley-VCH, 122-158 (2000). Jerkovich, A.D*, LoBrutto,R., and Vivilecchia, R.V., The Use of Acquity UPLC in Pharmaceutical Development, published in LC-GC,( 2005 ) Chan, F, Yeung, L.S, LoBrutto,R*, Kazakevich,Y*. Characterization of phenyl-type HPLC adsorbents Journal of Chromatography A, 1069, Issue 2,April 2005, 217-224. Kazakevich, Y*., LoBrutto,R* and Vivilecchia, R. Reversed-Phase HPLC Behavior of Chaotropic Counteranions, Journal of Chromatography, 1064, 9-18, (2005) Pan, L, LoBrutto, R.*, Kazakevich, Y.*, and Thompson, R. Influence of inorganic mobile phase additives on the retention, efficiency, and peak symmetry of protonated basic compounds in reversed phase liquid chromatography, Journal of Chromatography A, 1049, 63-73 (2004). Jones, A., LoBrutto, R*., Kazakevich, Y.V.* Effect of the counter-anion type and concentration on the HPLC retention of beta-blockers, Journal of Chromatography A, 964, 179-187 (2002). Rustamov, I., Farcas, T., Ahmed, F., Chan, F., LoBrutto, R., McNair, H.M,. Kazakevich, Y.V. Geometry of Chemically Modified Silica, Journal of Chromatography A, 913, 49 63 (2001). Kazakevich, Y.V., LoBrutto, R., Chan, F., Patel, T. Interpretation of the excess adsorption isotherms of organic eluent components on the surface of reversed phase adsorbents: Effect on the analyte retention, Journal of Chromatography A, 913, 75-87 (2001). LoBrutto, R., Jones, A., Kazakevich, Y.V. Effect of counter-anion concentration on HPLC retention of protonated basic analytes, Journal of Chromatography A, 913, 189 196 (2001). LoBrutto, R., Jones, A., Kazakevich, Y.V., McNair, H.M. Effect of the Eluent ph and Acidic Modifiers on the HPLC Retention of Basic Analytes, Journal of Chromatography A, 913, 173-187 (2001).